In graft vs. host disease (GvHD), the donated stem cells you receive during an allogeneic stem cell transplant view your body’s cells as a threat and attack. There are two main types of …

2024年6月7日 · Graft-versus-host disease (GVHD) is a systemic disorder occurring when immune cells from transplanted tissue recognize the recipient's body as foreign and attack its cells. In …

GVHD consists of inflammation induced by the conditioning regimen, the alloimmune response of the T lymphocytes, and organ damage due to the graft- vs -host reaction. Biological factors …

With ongoing monitoring and a multidisciplinary team of experts who know how to manage this disorder, the problems linked to GVHD may improve and even go away. The sooner treatment …

Furlan SN, Watkins B, Tkachev V, Cooley S, Panoskaltsis-Mortari A, Betz K, et al. Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and …

2023年6月8日 · Acute graft-versus-host disease (GVHD) is a common immune complication that can occur after allogeneic haematopoietic cell transplantation (alloHCT). Acute...

2021年12月10日 · Chronic graft-versus-host disease (GVHD) is the leading cause of late morbidity and mortality after allogeneic hematopoietic cell transplantation. Symptoms and …

Graft-versus-host disease (GVHD) occurs when alloreactive T cells from the donor attack healthy tissues in the recipient and arises almost exclusively in patients who have undergone …

2024年4月11日 · Acute graft-versus-host disease (GvHD) remains a major course of short term (100 days and 1 yr) mortality and morbidity after allogeneic stem cell transplantation.

Find information on graft-versus-host disease (GVHD), including the types, managing GVHD, your transplant journey, community support, and resources.